Compare AGIO & NOMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AGIO | NOMD |
|---|---|---|
| Founded | 2007 | 2014 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Packaged Foods |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.8B |
| IPO Year | 2013 | N/A |
| Metric | AGIO | NOMD |
|---|---|---|
| Price | $27.18 | $11.58 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 8 | 5 |
| Target Price | ★ $36.25 | $18.00 |
| AVG Volume (30 Days) | 1.5M | ★ 2.0M |
| Earning Date | 02-12-2026 | 03-02-2026 |
| Dividend Yield | N/A | ★ 5.71% |
| EPS Growth | N/A | ★ 4.79 |
| EPS | N/A | ★ 1.51 |
| Revenue | $44,791,000.00 | ★ $3,581,837,382.00 |
| Revenue This Year | $27.83 | N/A |
| Revenue Next Year | $134.79 | $1.32 |
| P/E Ratio | ★ N/A | $7.87 |
| Revenue Growth | ★ 36.26 | N/A |
| 52 Week Low | $22.24 | $11.04 |
| 52 Week High | $46.00 | $20.81 |
| Indicator | AGIO | NOMD |
|---|---|---|
| Relative Strength Index (RSI) | 45.23 | 34.05 |
| Support Level | $27.30 | $11.51 |
| Resistance Level | $28.87 | $12.12 |
| Average True Range (ATR) | 1.00 | 0.28 |
| MACD | 0.30 | -0.06 |
| Stochastic Oscillator | 26.55 | 7.26 |
Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology. The company's primary focus is to develop potentially transformative small-molecule medicines. Its product candidate, Pyrukynd (mitapivat), is an activator of both wild-type and mutant pyruvate kinase enzymes, developed for the treatment of hemolytic anemias. The other drug candidates in its pipeline include Tebapivat (PK activator), being developed as a potential treatment for MDS-associated anemia and sickle cell disease, AG-181 (PAH stabilizer), AG-236, and others.
Nomad Foods Ltd is a packaged foods company that is involved in the business of manufacturing and distribution of branded frozen foods in Western Europe. The company manufactures and markets frozen food products such as fish, vegetables, poultry, Ice Cream and ready meals like pizza. It sells its products through large grocery retailers under the brand Birds Eye in the United Kingdom and Ireland, Findus in Italy, France, Spain, and Scandinavia, and Iglo in Germany and other continental markets. The company operates through a single segment being Frozen. The majority of the revenue is generated from the United Kingdom.